BIM
SRPT icon

BlackRock Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

BlackRock Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.27M Buy
228,628
+26,815
+13% +$1.08M 0.01% 1426
2016
Q3 		$12.4M Buy
201,813
+34,025
+20% +$1.03M 0.02% 871
2016
Q2 		$3.2M Buy
167,788
+11,825
+8% +$219K ﹤0.01% 1759
2016
Q1 		$3.04M Buy
155,963
+11,492
+8% +$201K ﹤0.01% 1712
2015
Q4 		$5.57M Sell
144,471
-30,135
-17% -$977K 0.01% 1328
2015
Q3 		$5.61M Sell
174,606
-4,354
-2% -$148K 0.01% 1308
2015
Q2 		$5.45M Buy
178,960
+27,867
+18% +$570K 0.01% 1424
2015
Q1 		$2.01M Buy
151,093
+16,117
+12% +$215K ﹤0.01% 2020
2014
Q4 		$1.95M Buy
134,976
+23,285
+21% +$394K ﹤0.01% 2053
2014
Q3 		$2.36M Buy
111,691
+414
+0.4% +$9.34K ﹤0.01% 1882
2014
Q2 		$3.31M Buy
111,277
+7,584
+7% +$240K ﹤0.01% 1702
2014
Q1 		$2.49M Buy
103,693
+725
+0.7% +$18.5K ﹤0.01% 1887
2013
Q4 		$2.1M Buy
102,968
+8,353
+9% +$248K ﹤0.01% 1996
2013
Q3 		$4.47M Buy
94,615
+10,179
+12% +$392K 0.01% 1375
2013
Q2 		$3.21M Buy
+84,436
New +$3.02M 0.01% 1514

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Investment Management's SRPT Position: Q4 2016 in Review

BlackRock Investment Management increased its Sarepta Therapeutics (SRPT) stake by 13% in Q4 2016, buying an estimated $1.08M and bringing the position to 228,628 shares worth $6.27M. The position accounts for 0.01% of the portfolio, ranked #1426.

BlackRock Investment Management first reported a position in SRPT in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.4M in Q3 2016. 177 funds tracked by Wall St. Rank hold SRPT as of Q4 2016.

  • BlackRock Investment Management held 228,628 shares of Sarepta Therapeutics worth $6.27M as of Q4 2016.
  • BlackRock Investment Management bought 26,815 Sarepta Therapeutics shares in Q4 2016, an estimated $1.08M.
  • Sarepta Therapeutics made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1426 holding.
  • BlackRock Investment Management first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Sarepta Therapeutics position peaked at $12.4M in Q3 2016.
  • 177 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.